Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors

Alexander O. Pasternak, Jelmer Vroom, Neeltje A. Kootstra, Ferdinand W.N.M. Wit, Marijn de Bruin, Davide De Francesco, Margreet Bakker, Caroline A Sabin, Alan Winston, Jan M. Prins, Peter Reiss, Ben Berkhout on behalf of The Co-morBidity in Relation to Aids (COBRA) Collaboration and the AIMS Cohort Study
doi: https://doi.org/10.1101/2021.03.25.21254129

Article usage

Article usage: March 2021 to November 2024

AbstractFullPdf
Mar 2021166219
Apr 20212161712
May 202184510
Jun 20216718
Jul 20214026
Aug 20213294237
Sep 2021763723
Oct 2021701343
Nov 202155121
Dec 202138210
Jan 20222979
Feb 20222315
Mar 20222848
Apr 202247710
May 202233010
Jun 202224168
Jul 202225055
Aug 20222346
Sep 202237310
Oct 20228897
Nov 20225703
Dec 20221628
Jan 202319610
Feb 20232356
Mar 20231987
Apr 20232325
May 20231529
Jun 2023945
Jul 20231313
Aug 202319125
Sep 20232164
Oct 20231738
Nov 202325119
Dec 20232025
Jan 20241733
Feb 20241739
Mar 20241554
Apr 202411310
May 2024934
Jun 20242366
Jul 202428714
Aug 202417714
Sep 20242895
Oct 202415510
Nov 2024628
Back to top
Posted March 26, 2021.
Download PDF
Data/Code
Email
Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors
Alexander O. Pasternak, Jelmer Vroom, Neeltje A. Kootstra, Ferdinand W.N.M. Wit, Marijn de Bruin, Davide De Francesco, Margreet Bakker, Caroline A Sabin, Alan Winston, Jan M. Prins, Peter Reiss, Ben Berkhout
medRxiv 2021.03.25.21254129; doi: https://doi.org/10.1101/2021.03.25.21254129
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area